KBC Group’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-6,454
| Closed | -$2.56M | – | 1334 |
|
|
2020
Q4 | $2.56M | Hold |
6,454
| – | – | ﹤0.01% | 1008 |
|
|
2020
Q3 | $294K | Hold |
6,454
| – | – | ﹤0.01% | 1071 |
|
|
2020
Q2 | $292K | Buy |
6,454
+3,227
| +100% | +$145K | ﹤0.01% | 1112 |
|
|
2020
Q1 | $124K | Sell |
3,227
-13,852
| -81% | -$638K | ﹤0.01% | 1110 |
|
|
2019
Q4 | $791K | Hold |
17,079
| – | – | 0.01% | 969 |
|
|
2019
Q3 | $696K | Sell |
17,079
-19,295
| -53% | -$833K | 0.01% | 994 |
|
|
2019
Q2 | $1.75M | Hold |
36,374
| – | – | 0.01% | 642 |
|
|
2019
Q1 | $2.28M | Buy |
36,374
+14,436
| +66% | +$992K | 0.02% | 584 |
|
|
2018
Q4 | $1.31M | Sell |
21,938
-9,203
| -30% | -$553K | 0.01% | 659 |
|
|
2018
Q3 | $2.01M | Buy |
+31,141
| New | +$1.74M | 0.02% | 676 |
|
|
2018
Q1 | – | Sell |
-20,669
| Closed | -$618K | – | 1349 |
|
|
2017
Q4 | $618K | Sell |
20,669
-40,434
| -66% | -$1.17M | 0.01% | 921 |
|
|
2017
Q3 | $2.02M | Sell |
61,103
-27,195
| -31% | -$942K | 0.02% | 604 |
|
|
2017
Q2 | $2.95M | Buy |
88,298
+7,019
| +9% | +$209K | 0.03% | 494 |
|
|
2017
Q1 | $2.35M | Buy |
81,279
+6,688
| +9% | +$166K | 0.02% | 604 |
|
|
2016
Q4 | $1.67M | Buy |
74,591
+30,501
| +69% | +$596K | 0.02% | 684 |
|
|
2016
Q3 | $819K | Buy |
+44,090
| New | +$832K | 0.01% | 827 |
|
Other funds holding BEAT
KBC Group's BEAT Position: Q1 2021 in Review
KBC Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 6,454 shares — an estimated $2.56M sold.
KBC Group first reported a position in BEAT in Q3 2016 and held it in 16 quarters. The position peaked at $2.95M in Q2 2017. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- KBC Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- KBC Group sold 6,454 BioTelemetry, Inc. shares in Q1 2021, an estimated $2.56M.
- KBC Group first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 16 quarters.
- KBC Group's BioTelemetry, Inc. position peaked at $2.95M in Q2 2017.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on KBC Group's 13F filing for Q1 2021, filed 26 Apr 2021.